RetiPharma IVS: Financial statements 2018
CVR: 37134120
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
RetiPharma IVS (CVR 37134120) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -147,051 and a net result of DKK -203,870 compared with DKK 0 the year before. Equity in the 2018 report amounted to DKK -190,437.
- Gross Profit
- DKK -147,051
- Profit/Loss
- DKK -203,870
- Equity
- DKK -190,437
- Total Assets
- DKK 6,582,356
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of August 30, 2018, inforevision statsautoriseret revisionsaktieselskab has been appointed auditor of RetiPharma IVS.
RetiPharma IVS has published its annual report for 2017. Revenue came to DKK 0, and the net result was DKK 0.
As of April 16, 2018, Jørgen Axel Thorball has joined the board of directors of RetiPharma IVS.
As of April 16, 2018, Casper Tind Hansen has joined the board of directors of RetiPharma IVS.
As of April 16, 2018, David Paul Drucker Woldbye has joined the board of directors of RetiPharma IVS.
As of April 16, 2018, Henrik Vissing is registered as adm. dir. of RetiPharma IVS.
As of April 16, 2018, Morten Albrechtsen is registered as chairman of RetiPharma IVS.
As of April 16, 2018, Kristian Klemp has stepped down as director of RetiPharma IVS.
As of April 16, 2018, David Paul Drucker Woldbye has stepped down as adm. dir. of RetiPharma IVS.
On April 16, 2018, the company changed its name from RetiCare IVS to RetiPharma IVS.
About RetiPharma IVS
RetiPharma IVS was a Danish company of the type Iværksætterselskab based in København N, founded in 2015. The company has been dissolved on 25 September 2020. The company was registered under the industry Anden teknisk rådgivning. The company was previously named RetiCare IVS. The company has 3 employees (2020). In 2018, the company reported a gross profit of DKK -147,051 and a net result of DKK -203,870 compared with DKK 0 the year before. Equity in the 2018 report amounted to DKK -190,437.